Merit Medical Systems, Inc. (MMSI)
BiotechSign Signal Grade
Composite of clinical trial activity, dilution exposure, publications, short interest, and insider transactions — all from verified public filings.
Pipeline Overview
- Therapeutic Focus
- Biotech / Pharmasrc
Clinical Trial Activity
(ClinicalTrials.gov aggregate)
ClinicalTrials.gov aggregate as of 2026-10-13. ClinicalTrials.gov
Dilution Risk
LOW DILUTION RISKDilution score: 10/100 (LOW), cash runway not available
Derived from verified regulatory filings. Measures dilution exposure from warrants, convertibles, and offering history. DilutionWatch SEC-derived score
Short Interest
Short interest: 6.24% of float, squeeze risk: MODERATE
FINRA short sale data. FINRA short interest
Recent News & SEC Filings
- Medical Devices & Supplies - Cardiology, Neurology, Vascular Q2 Earnings: Merit Medical Systems (NASDAQ:MMSI) Simply the Best
- Merit Medical Systems (MMSI) Rallies On Margin Progress, Is The Stock Still Cheap?
- Merit Medical Systems (MMSI) Stock Looks Cheap Based On Cash Flow
- OPKO Health to Sell Select BioReference Assets to Labcorp for $722M
- BD's Revello Stent Shows Strong AGILITY Trial Results for PAD Patients
- Doximity Deepens U.S. News Alliance to Improve Patient Access to Care
- West Pharmaceutical Stock Gains 36.1% YTD: What's Behind the Rally?
- Glaukos Stock Gains 36.8% in 6 Months: What's Behind the Rally?
Headlines from public sources. BiotechSign does not endorse or verify linked content.
Get real-time catalyst alerts, analyst signals, dilution risk tracking, and full pipeline data for Merit Medical Systems, Inc..
Full MMSI Dashboard Sign Up FreePrimary Sources
This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.